2020 Q4 Form 10-Q Financial Statement

#000110852420000047 Filed on December 04, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4 2019 Q3
Revenue $5.419B $4.513B $3.997B
YoY Change 20.08% 33.05% 21.82%
Cost Of Revenue $1.394B $1.134B $967.0M
YoY Change 22.93% 27.56% 13.9%
Gross Profit $4.025B $3.379B $3.030B
YoY Change 19.12% 35.0% 24.59%
Gross Profit Margin 74.28% 74.87% 75.81%
Selling, General & Admin $2.899B $2.540B $2.199B
YoY Change 14.13% 31.61% 18.61%
% of Gross Profit 72.02% 75.17% 72.57%
Research & Development $902.0M $774.0M $607.0M
YoY Change 16.54% 60.91% 31.1%
% of Gross Profit 22.41% 22.91% 20.03%
Depreciation & Amortization $670.0M $608.0M $457.0M
YoY Change 10.2% 137.5% 81.35%
% of Gross Profit 16.65% 17.99% 15.08%
Operating Expenses $3.801B $3.314B $2.972B
YoY Change 14.7% 37.45% 28.27%
Operating Profit $224.0M $65.00M $58.00M
YoY Change 244.62% -29.35% -49.57%
Interest Expense $1.030B $7.000M $106.0M
YoY Change 14614.29% -82.5% 171.79%
% of Operating Profit 459.82% 10.77% 182.76%
Other Income/Expense, Net -$4.000M -$7.000M -$3.000M
YoY Change -42.86% -74.07% -88.89%
Pretax Income $1.250B $64.00M $164.0M
YoY Change 1853.13% -50.0% -29.0%
Income Tax $169.0M $173.0M $73.00M
% Of Pretax Income 13.52% 270.31% 44.51%
Net Earnings $1.081B -$109.0M $91.00M
YoY Change -1091.74% -203.81% -69.57%
Net Earnings / Revenue 19.95% -2.42% 2.28%
Basic Earnings Per Share $1.19 -$0.12 $0.12
Diluted Earnings Per Share $1.15 -$0.12 $0.11
COMMON SHARES
Basic Shares Outstanding 911.0M shares 879.0M shares 776.0M shares
Diluted Shares Outstanding 939.0M shares 879.0M shares 795.0M shares

Balance Sheet

Concept 2020 Q4 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.492B $6.529B $6.042B
YoY Change 45.38% 89.25% 76.31%
Cash & Equivalents $3.724B $3.868B $3.510B
Short-Term Investments $5.768B $2.661B $2.532B
Other Short-Term Assets $1.121B $1.111B $743.0M
YoY Change 0.9% 66.57% 8.15%
Inventory
Prepaid Expenses
Receivables $3.316B $2.573B $2.332B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.95B $11.03B $9.903B
YoY Change 35.55% 60.49% 45.59%
LONG-TERM ASSETS
Property, Plant & Equipment $2.564B $2.365B $2.283B
YoY Change 8.41% 18.37% 14.95%
Goodwill $26.31B $25.02B $13.20B
YoY Change 5.16% 94.75% 7.71%
Intangibles $4.398B $4.987B $1.725B
YoY Change -11.81% 142.91% -12.7%
Long-Term Investments $3.927B $1.760B $1.614B
YoY Change 123.13% 40.69% 34.28%
Other Assets $2.564B $529.0M $603.0M
YoY Change 384.69% 21.33% 31.37%
Total Long-Term Assets $44.19B $38.92B $23.43B
YoY Change 13.55% 97.36% 23.2%
TOTAL ASSETS
Total Short-Term Assets $14.95B $11.03B $9.903B
Total Long-Term Assets $44.19B $38.92B $23.43B
Total Assets $59.14B $49.94B $33.34B
YoY Change 18.41% 87.84% 29.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.546B $2.763B $2.271B
YoY Change 28.34% 1626.88% 1029.85%
Accrued Expenses $765.0M $735.0M $706.0M
YoY Change 4.08% -30.0% -27.74%
Deferred Revenue $7.923B $6.858B $7.142B
YoY Change 15.53% 27.57% 21.4%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.000M $3.000M $4.000M
YoY Change 33.33% -99.4% -99.2%
Total Short-Term Liabilities $12.23B $10.47B $10.20B
YoY Change 16.8% 30.57% 20.38%
LONG-TERM LIABILITIES
Long-Term Debt $2.672B $2.824B $2.973B
YoY Change -5.38% -11.0% -6.3%
Other Long-Term Liabilities $1.517B $830.0M $661.0M
YoY Change 82.77% 18.57% 1.23%
Total Long-Term Liabilities $4.189B $3.654B $3.634B
YoY Change 14.64% -5.65% -5.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.23B $10.47B $10.20B
Total Long-Term Liabilities $4.189B $3.654B $3.634B
Total Liabilities $18.83B $16.66B $16.17B
YoY Change 12.98% 40.08% 31.52%
SHAREHOLDERS EQUITY
Retained Earnings $5.666B $2.109B $2.218B
YoY Change 168.66% 53.61% 74.78%
Common Stock $34.73B $31.24B $15.03B
YoY Change 11.15% 133.27% 22.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $40.31B $33.28B $17.17B
YoY Change
Total Liabilities & Shareholders Equity $59.14B $49.94B $33.34B
YoY Change 18.41% 87.84% 29.09%

Cashflow Statement

Concept 2020 Q4 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income $1.081B -$109.0M $91.00M
YoY Change -1091.74% -203.81% -69.57%
Depreciation, Depletion And Amortization $670.0M $608.0M $457.0M
YoY Change 10.2% 137.5% 81.35%
Cash From Operating Activities $339.0M $298.0M $436.0M
YoY Change 13.76% 108.39% -4.8%
INVESTING ACTIVITIES
Capital Expenditures $124.0M $170.0M $178.0M
YoY Change -27.06% 25.0% 4.71%
Acquisitions $24.00M -$94.00M $423.0M
YoY Change -125.53% -172.31% -91.19%
Other Investing Activities -$911.0M $233.0M -$674.0M
YoY Change -490.99% -156.97% -84.99%
Cash From Investing Activities -$1.035B $63.00M -$852.0M
YoY Change -1742.86% -111.56% -81.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $368.0M $15.00M -$183.0M
YoY Change 2353.33% -91.76% -131.07%
NET CHANGE
Cash From Operating Activities $339.0M $298.0M $436.0M
Cash From Investing Activities -$1.035B $63.00M -$852.0M
Cash From Financing Activities $368.0M $15.00M -$183.0M
Net Change In Cash -$328.0M $358.0M -$600.0M
YoY Change -191.62% -267.29% -83.35%
FREE CASH FLOW
Cash From Operating Activities $339.0M $298.0M $436.0M
Capital Expenditures $124.0M $170.0M $178.0M
Free Cash Flow $215.0M $128.0M $258.0M
YoY Change 67.97% 1728.57% -10.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001108524
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-10-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-32224
dei Entity Registrant Name
EntityRegistrantName
salesforce.com, inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3320693
dei Entity Address Address Line1
EntityAddressAddressLine1
Salesforce Tower
dei Entity Address Address Line2
EntityAddressAddressLine2
415 Mission Street, 3rd Fl
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94105
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
901-7000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
CRM
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
915000000 shares
CY2019Q4 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
346000000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3724000000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4145000000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
5768000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
3802000000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3316000000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6174000000 USD
CY2020Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
1017000000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
926000000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1121000000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
916000000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
14946000000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
15963000000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2564000000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2375000000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2962000000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3040000000 USD
CY2020Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
1462000000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
1348000000 USD
CY2020Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
3927000000 USD
CY2020Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
1963000000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
26313000000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
25134000000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4398000000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4724000000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2564000000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
579000000 USD
CY2020Q4 us-gaap Assets
Assets
59136000000 USD
CY2020Q1 us-gaap Assets
Assets
55126000000 USD
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
3546000000 USD
CY2020Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
3433000000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
765000000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
750000000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7923000000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10662000000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12234000000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
14845000000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2672000000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2673000000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2403000000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2445000000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1517000000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1278000000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
18826000000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
21241000000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1000000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
1000000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
34727000000 USD
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
32116000000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-84000000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-93000000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5666000000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1861000000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
40310000000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
33885000000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
59136000000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55126000000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5419000000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4513000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15435000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12247000000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1394000000 USD
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1134000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3959000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3015000000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
4025000000 USD
CY2019Q4 us-gaap Gross Profit
GrossProfit
3379000000 USD
us-gaap Gross Profit
GrossProfit
11476000000 USD
us-gaap Gross Profit
GrossProfit
9232000000 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
902000000 USD
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
774000000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2659000000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1935000000 USD
CY2020Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2377000000 USD
CY2019Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2063000000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7042000000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5584000000 USD
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
522000000 USD
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
477000000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1513000000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1214000000 USD
CY2020Q4 crm Fair Value Adjustment Loss On Remaining Performance Obligations Of Agreements
FairValueAdjustmentLossOnRemainingPerformanceObligationsOfAgreements
0 USD
CY2019Q4 crm Fair Value Adjustment Loss On Remaining Performance Obligations Of Agreements
FairValueAdjustmentLossOnRemainingPerformanceObligationsOfAgreements
0 USD
crm Fair Value Adjustment Loss On Remaining Performance Obligations Of Agreements
FairValueAdjustmentLossOnRemainingPerformanceObligationsOfAgreements
0 USD
crm Fair Value Adjustment Loss On Remaining Performance Obligations Of Agreements
FairValueAdjustmentLossOnRemainingPerformanceObligationsOfAgreements
166000000 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
3801000000 USD
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
3314000000 USD
us-gaap Operating Expenses
OperatingExpenses
11214000000 USD
us-gaap Operating Expenses
OperatingExpenses
8899000000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
224000000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
65000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
262000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
333000000 USD
CY2020Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
1036000000 USD
CY2019Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
6000000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
1910000000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
396000000 USD
CY2020Q4 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
10000000 USD
CY2019Q4 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
7000000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
36000000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
19000000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1250000000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
64000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2136000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
710000000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
169000000 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
173000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1669000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
336000000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
1081000000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-109000000 USD
us-gaap Net Income Loss
NetIncomeLoss
3805000000 USD
us-gaap Net Income Loss
NetIncomeLoss
374000000 USD
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.19
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.15
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
911000000 shares
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
879000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
905000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
809000000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
939000000 shares
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
879000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
926000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
829000000 shares
CY2020Q3 us-gaap Income Tax Reconciliation Disposition Of Assets
IncomeTaxReconciliationDispositionOfAssets
-2000000000.0 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
1081000000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-109000000 USD
us-gaap Net Income Loss
NetIncomeLoss
3805000000 USD
us-gaap Net Income Loss
NetIncomeLoss
374000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-6000000 USD
CY2019Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-1000000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-1000000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-31000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-11000000 USD
CY2019Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
4000000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
13000000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
18000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-17000000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
3000000 USD
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
12000000 USD
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-13000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-1000000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0 USD
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
3000000 USD
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
3000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16000000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
9000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16000000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1065000000 USD
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-106000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3814000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
358000000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
33885000000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
119000000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
504000000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-42000000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
99000000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
34565000000 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
605000000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
578000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
67000000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
2625000000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
38440000000 USD
CY2020Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
239000000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
566000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16000000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
1081000000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
40310000000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
15605000000 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
113000000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
343000000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7000000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
392000000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
16446000000 USD
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
253000000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
388000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12000000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
91000000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
17166000000 USD
CY2019Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
88000000 USD
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
543000000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
15588000000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3000000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-109000000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
33279000000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
1081000000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-109000000 USD
us-gaap Net Income Loss
NetIncomeLoss
3805000000 USD
us-gaap Net Income Loss
NetIncomeLoss
374000000 USD
CY2020Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
670000000 USD
CY2019Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
608000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1977000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1502000000 USD
CY2020Q4 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
271000000 USD
CY2019Q4 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
221000000 USD
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
768000000 USD
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
647000000 USD
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
566000000 USD
CY2019Q4 us-gaap Share Based Compensation
ShareBasedCompensation
543000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1648000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1274000000 USD
CY2020Q4 crm Fair Value Adjustment Loss On Remaining Performance Obligations Of Agreements
FairValueAdjustmentLossOnRemainingPerformanceObligationsOfAgreements
0 USD
CY2019Q4 crm Fair Value Adjustment Loss On Remaining Performance Obligations Of Agreements
FairValueAdjustmentLossOnRemainingPerformanceObligationsOfAgreements
0 USD
crm Fair Value Adjustment Loss On Remaining Performance Obligations Of Agreements
FairValueAdjustmentLossOnRemainingPerformanceObligationsOfAgreements
0 USD
crm Fair Value Adjustment Loss On Remaining Performance Obligations Of Agreements
FairValueAdjustmentLossOnRemainingPerformanceObligationsOfAgreements
166000000 USD
CY2020Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
1036000000 USD
CY2019Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
6000000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
1910000000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
396000000 USD
CY2020Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2019Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2003000000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2020Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-128000000 USD
CY2019Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
29000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2873000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2599000000 USD
CY2020Q4 crm Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
493000000 USD
CY2019Q4 crm Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
246000000 USD
crm Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
973000000 USD
crm Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
543000000 USD
CY2020Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-80000000 USD
CY2019Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
183000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
134000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
252000000 USD
CY2020Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
68000000 USD
CY2019Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
265000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13000000 USD
CY2020Q4 crm Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-204000000 USD
CY2019Q4 crm Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-200000000 USD
crm Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-616000000 USD
crm Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-546000000 USD
CY2020Q4 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-792000000 USD
CY2019Q4 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-566000000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2812000000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2139000000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
339000000 USD
CY2019Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
298000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2627000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2699000000 USD
CY2020Q4 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
24000000 USD
CY2019Q4 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-94000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1281000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
339000000 USD
CY2020Q4 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
368000000 USD
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
942000000 USD
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
567000000 USD
CY2020Q4 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
33000000 USD
CY2019Q4 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
138000000 USD
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
685000000 USD
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
403000000 USD
CY2020Q4 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1453000000 USD
CY2019Q4 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
438000000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
3968000000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1944000000 USD
CY2020Q4 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
662000000 USD
CY2019Q4 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
427000000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1206000000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
888000000 USD
CY2020Q4 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
239000000 USD
CY2019Q4 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
358000000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
796000000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
551000000 USD
CY2020Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
124000000 USD
CY2019Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
170000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
561000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
507000000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1035000000 USD
CY2019Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
63000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4065000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1515000000 USD
CY2020Q4 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
381000000 USD
CY2019Q4 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
179000000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1105000000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
550000000 USD
CY2020Q4 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
12000000 USD
CY2019Q4 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
14000000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
84000000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
159000000 USD
CY2020Q4 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
1000000 USD
CY2019Q4 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
150000000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
3000000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
352000000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
368000000 USD
CY2019Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1018000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39000000 USD
CY2020Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 USD
CY2019Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-18000000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1000000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-24000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-328000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
358000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-421000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1199000000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4052000000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3510000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4145000000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2669000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3724000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3868000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3724000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3868000000 USD
CY2020Q4 us-gaap Interest Paid Net
InterestPaidNet
46000000 USD
CY2019Q4 us-gaap Interest Paid Net
InterestPaidNet
48000000 USD
us-gaap Interest Paid Net
InterestPaidNet
94000000 USD
us-gaap Interest Paid Net
InterestPaidNet
104000000 USD
CY2020Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
56000000 USD
CY2019Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
38000000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
180000000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
93000000 USD
CY2020Q4 crm Business Combination Consideration Transferred Fair Value Of Equity Awards Assumed
BusinessCombinationConsiderationTransferredFairValueOfEquityAwardsAssumed
0 USD
CY2019Q4 crm Business Combination Consideration Transferred Fair Value Of Equity Awards Assumed
BusinessCombinationConsiderationTransferredFairValueOfEquityAwardsAssumed
373000000 USD
crm Business Combination Consideration Transferred Fair Value Of Equity Awards Assumed
BusinessCombinationConsiderationTransferredFairValueOfEquityAwardsAssumed
6000000 USD
crm Business Combination Consideration Transferred Fair Value Of Equity Awards Assumed
BusinessCombinationConsiderationTransferredFairValueOfEquityAwardsAssumed
373000000 USD
CY2020Q4 crm Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsideration
0 USD
CY2019Q4 crm Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsideration
15215000000 USD
crm Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsideration
0 USD
crm Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsideration
15215000000 USD
us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year ends on January 31. References to fiscal 2021, for example, refer to the fiscal year ending January 31, 2021.</span></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions in the Company’s condensed consolidated financial statements and notes thereto.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates and assumptions made by management include the determination of:</span></div><div style="margin-top:3.25pt;padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the fair value of assets acquired and liabilities assumed for business combinations;</span></div><div style="margin-top:3.25pt;padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the standalone selling price (“SSP”) of performance obligations for revenue contracts with multiple performance obligations;</span></div><div style="margin-top:3.25pt;padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the valuation of privately-held strategic investments, including impairments;</span></div><div style="margin-top:3.25pt;padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the recognition, measurement and valuation of current and deferred income taxes and uncertain tax positions;</span></div><div style="margin-top:3.25pt;padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the average period of benefit associated with costs capitalized to obtain revenue contracts; </span></div><div style="margin-top:3.25pt;padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the useful lives of intangible assets; and</span></div><div style="margin-top:3.25pt;padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the fair value of certain stock awards issued.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual results could differ materially from those estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the result of which forms the basis for making judgments about the carrying values of assets and liabilities. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the novel coronavirus and resulting disease (“COVID-19”) was reported and in March 2020 the World Health Organization declared it a pandemic. The extent of the impact of the COVID-19 pandemic on the Company’s operational and financial performance depends on certain developments, including the duration of the pandemic, impact on the </span></div>Company’s customers and its sales and renewal cycles, and impact on the Company’s employees, as discussed in more detail in Part I, Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations”. These estimates may change, as new events occur and additional information is obtained, and such changes will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from these estimates and any such differences may be material to the Company’s financial statements.
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk, Significant Customers and Investments</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities and accounts receivable. Collateral is not required for accounts receivable. The Company maintains an allowance for its doubtful accounts receivable due to estimated credit losses. This allowance is based upon historical loss patterns, the number of days that billings are past due, an evaluation of the potential risk of loss associated with delinquent accounts and current market conditions and reasonable and supportable forecasts of future economic conditions to inform adjustments to historical loss patterns. The Company records the allowance against bad debt expense through the condensed consolidated statement of operations up to the amount of revenues recognized to date. Any incremental allowance is recorded as an offset to unearned revenue on the condensed consolidated balance sheet. Receivables are written-off and charged against the recorded allowance when the Company has exhausted collection efforts without success. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single customer accounted for more than five percent of accounts receivable at October 31, 2020 and January 31, 2020. No single customer accounted for five percent or more of total revenue during the nine months ended October 31, 2020 and 2019. As of October 31, 2020 and January 31, 2020, assets located outside the Americas were 13 percent and 12 percent of total assets, respectively. As of October 31, 2020 and January 31, 2020, assets located in the United States were 85 percent and 87 percent of total assets, respectively.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also exposed to concentrations of risk in its strategic investment portfolio. As of October 31, 2020, the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company held one publicly traded investment with a carrying value that was individually greater than 35 percent of its total</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">strategic investments, one publicly traded investment with a carrying value that was individually approximately 20 percent of its total strategic investments and one privately held investment individually greater than five percent of its total strategic investments. As of January 31, 2020, the Company held five investments that were individually greater than five percent of its total strategic investments, of which one was publicly traded and four were privately held. The publicly traded investments held as of October 31, 2020 are different than the publicly traded investment that was held as of January 31, 2020.</span></div>
CY2020Q4 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P4Y
crm Capitalized Contract Cost Renewals And Success Fees Amortization Term
CapitalizedContractCostRenewalsAndSuccessFeesAmortizationTerm
P2Y
crm Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
973000000 USD
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
768000000 USD
crm Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
543000000 USD
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
647000000 USD
CY2020Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
2500000000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
2300000000 USD
CY2020Q4 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2019Q4 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
crm Sharebased Compensation Arrangementby Sharebased Payment Award Award Offering Period
SharebasedCompensationArrangementbySharebasedPaymentAwardAwardOfferingPeriod
P12M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.15
crm Sharebased Compensation Arrangementby Sharebased Payment Award Purchase Period
SharebasedCompensationArrangementbySharebasedPaymentAwardPurchasePeriod
P6M
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5419000000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4513000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15435000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12247000000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
574000000 USD
CY2020Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
449000000 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8711000000 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7142000000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10662000000 USD
CY2019Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8564000000 USD
CY2020Q4 crm Contract With Customer Liability Billings And Other
ContractWithCustomerLiabilityBillingsAndOther
4561000000 USD
CY2019Q4 crm Contract With Customer Liability Billings And Other
ContractWithCustomerLiabilityBillingsAndOther
3886000000 USD
crm Contract With Customer Liability Billings And Other
ContractWithCustomerLiabilityBillingsAndOther
12498000000 USD
crm Contract With Customer Liability Billings And Other
ContractWithCustomerLiabilityBillingsAndOther
9996000000 USD
CY2020Q4 crm Contract With Customer Liability Contribution From Contract Asset
ContractWithCustomerLiabilityContributionFromContractAsset
66000000 USD
CY2019Q4 crm Contract With Customer Liability Contribution From Contract Asset
ContractWithCustomerLiabilityContributionFromContractAsset
61000000 USD
crm Contract With Customer Liability Contribution From Contract Asset
ContractWithCustomerLiabilityContributionFromContractAsset
125000000 USD
crm Contract With Customer Liability Contribution From Contract Asset
ContractWithCustomerLiabilityContributionFromContractAsset
112000000 USD
CY2020Q4 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
4000000 USD
CY2019Q4 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
282000000 USD
us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
73000000 USD
us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
433000000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7923000000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6858000000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7923000000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6858000000 USD
CY2020Q4 crm Revenue Remaining Performance Obligation Current
RevenueRemainingPerformanceObligationCurrent
15300000000 USD
CY2020Q4 crm Revenue Remaining Performance Obligation Noncurrent
RevenueRemainingPerformanceObligationNoncurrent
15000000000.0 USD
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
30300000000 USD
CY2020Q1 crm Revenue Remaining Performance Obligation Current
RevenueRemainingPerformanceObligationCurrent
15000000000.0 USD
CY2020Q1 crm Revenue Remaining Performance Obligation Noncurrent
RevenueRemainingPerformanceObligationNoncurrent
15800000000 USD
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
30800000000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
5737000000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
35000000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4000000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
5768000000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3789000000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
14000000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3802000000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2187000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1332000000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
3575000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2466000000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
6000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
4000000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
5768000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3802000000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
966000000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
4000000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
966000000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
4000000 USD
crm Unrealized Losses On Fixed Rate Investments Upper Range Value
UnrealizedLossesOnFixedRateInvestmentsUpperRangeValue
1000000 USD
CY2020Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
17000000 USD
CY2019Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
32000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
63000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
89000000 USD
CY2020Q4 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
4000000 USD
CY2019Q4 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0 USD
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
6000000 USD
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
1000000 USD
CY2020Q4 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
2000000 USD
CY2019Q4 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
0 USD
us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
3000000 USD
us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
1000000 USD
CY2020Q4 us-gaap Investment Income Net
InvestmentIncomeNet
19000000 USD
CY2019Q4 us-gaap Investment Income Net
InvestmentIncomeNet
32000000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
66000000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
89000000 USD
CY2020Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
3927000000 USD
CY2020Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
1963000000 USD
CY2020Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1537000000 USD
CY2019Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
917000000 USD
CY2020Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1502000000 USD
CY2019Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
785000000 USD
CY2020Q4 crm Strategic Investments Net Additions Reductions
StrategicInvestmentsNetAdditionsReductions
-55000000 USD
CY2019Q4 crm Strategic Investments Net Additions Reductions
StrategicInvestmentsNetAdditionsReductions
322000000 USD
crm Strategic Investments Net Additions Reductions
StrategicInvestmentsNetAdditionsReductions
1000000 USD
crm Strategic Investments Net Additions Reductions
StrategicInvestmentsNetAdditionsReductions
333000000 USD
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
31000000 USD
CY2019Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
81000000 USD
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
86000000 USD
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
253000000 USD
CY2020Q4 crm Equity Securities Without Readily Determinable Fair Value Impairment Loss And Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAndDownwardPriceAdjustmentAnnualAmount
6000000 USD
CY2019Q4 crm Equity Securities Without Readily Determinable Fair Value Impairment Loss And Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAndDownwardPriceAdjustmentAnnualAmount
3000000 USD
crm Equity Securities Without Readily Determinable Fair Value Impairment Loss And Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAndDownwardPriceAdjustmentAnnualAmount
82000000 USD
crm Equity Securities Without Readily Determinable Fair Value Impairment Loss And Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAndDownwardPriceAdjustmentAnnualAmount
54000000 USD
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1507000000 USD
CY2019Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1317000000 USD
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1507000000 USD
CY2019Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1317000000 USD
CY2020Q4 crm Equity Securitieswithout Readily Determinable Fair Value Impairment Lossand Downward Price Adjustment Cumulative Amount
EquitySecuritieswithoutReadilyDeterminableFairValueImpairmentLossandDownwardPriceAdjustmentCumulativeAmount
184000000 USD
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
540000000 USD
CY2020Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
1036000000 USD
CY2019Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
6000000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
1910000000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
396000000 USD
CY2020Q4 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
18000000 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
545000000 USD
CY2020Q4 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1000000000.0 USD
CY2020Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
370000000 USD
CY2020Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
6239000000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1600000000 USD
CY2020Q4 us-gaap Impairment Of Investments
ImpairmentOfInvestments
8000000 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
99000000 USD
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
2261000000 USD
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
10228000000 USD
CY2020Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
41000000 USD
CY2020Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
24000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6922000000 USD
crm Finite Lived Intangible Assets Additions And Retirements Net
FiniteLivedIntangibleAssetsAdditionsAndRetirementsNet
512000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7434000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2198000000 USD
crm Finite Lived Intangible Assets Amortization Expense And Retirements Net
FiniteLivedIntangibleAssetsAmortizationExpenseAndRetirementsNet
838000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3036000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4724000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4398000000 USD
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P5Y3M18D
CY2020Q4 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
283000000 USD
CY2019Q4 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
266000000 USD
us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
838000000 USD
us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
522000000 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
284000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1078000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
923000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
835000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
568000000 USD
CY2020Q4 crm Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
710000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4398000000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
25134000000 USD
us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
81000000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
26313000000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2676000000 USD
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2677000000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4000000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
4000000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2672000000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2673000000 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1000000 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
4000000 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
4000000 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1182000000 USD
CY2020Q4 crm Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
1500000000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
2691000000 USD
CY2020Q4 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
24000000 USD
CY2019Q4 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
26000000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
72000000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
82000000 USD
CY2020Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1000000 USD
CY2019Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1000000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3000000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3000000 USD
CY2020Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
25000000 USD
CY2019Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
27000000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
75000000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
85000000 USD
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
150000000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
1600000000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
1500000000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
59.54
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
40.52
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
35.31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
39.65
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
27000000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
98.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
8000000 shares
CY2019Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
145.30
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10000000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
79.77
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
133.43
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
24000000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
118.31
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2765000000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
22000000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
115.96
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2611000000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
10000000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
82.86
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1523000000 USD
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
154.14
CY2020Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
24000000 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P4Y10M24D
CY2020Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
118.31
CY2020Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
10000000 shares
CY2020Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
82.86
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1600000000 USD
CY2020Q4 crm Sharebased Compensation Arrangementby Sharebased Payment Award Amortization Remainingof Fiscal Year
SharebasedCompensationArrangementbySharebasedPaymentAwardAmortizationRemainingofFiscalYear
526000000 USD
CY2020Q4 crm Share Based Compensation Arrangement By Share Based Payment Award Amortization Year One
ShareBasedCompensationArrangementByShareBasedPaymentAwardAmortizationYearOne
1752000000 USD
CY2020Q4 crm Sharebased Compensation Arrangementby Sharebased Payment Award Amortization Year Two
SharebasedCompensationArrangementbySharebasedPaymentAwardAmortizationYearTwo
1283000000 USD
CY2020Q4 crm Sharebased Compensation Arrangementby Sharebased Payment Award Amortization Year Three
SharebasedCompensationArrangementbySharebasedPaymentAwardAmortizationYearThree
718000000 USD
CY2020Q4 crm Sharebased Compensation Arrangementby Sharebased Payment Award Amortization Year Four
SharebasedCompensationArrangementbySharebasedPaymentAwardAmortizationYearFour
138000000 USD
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4417000000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
143000000 shares
CY2020Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
133000000 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1700000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2100000000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.78
CY2020Q3 us-gaap Income Tax Reconciliation Disposition Of Assets
IncomeTaxReconciliationDispositionOfAssets
-2000000000.0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
336000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
710000000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.47
CY2020Q4 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
6000000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
1081000000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-109000000 USD
us-gaap Net Income Loss
NetIncomeLoss
3805000000 USD
us-gaap Net Income Loss
NetIncomeLoss
374000000 USD
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
911000000 shares
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
879000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
905000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
809000000 shares
CY2020Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
28000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
21000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
20000000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
939000000 shares
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
879000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
926000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
829000000 shares
CY2020Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
crm Lessee Operating Lease Termination Period
LesseeOperatingLeaseTerminationPeriod
P1Y
CY2020Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
278000000 USD
CY2019Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
230000000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
815000000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
653000000 USD
CY2020Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
222000000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
672000000 USD
CY2020Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
196000000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
562000000 USD
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.025
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P18Y
CY2020Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.042
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
222000000 USD
CY2020Q4 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
8000000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
784000000 USD
CY2020Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
34000000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
605000000 USD
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
35000000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
434000000 USD
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
35000000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
327000000 USD
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
31000000 USD
CY2020Q4 crm Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
1111000000 USD
CY2020Q4 crm Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
410000000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3483000000 USD
CY2020Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
553000000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
315000000 USD
CY2020Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
174000000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3168000000 USD
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
379000000 USD
CY2020Q4 crm Lessor Operating Lease Payments To Be Received Next Five Years
LessorOperatingLeasePaymentsToBeReceivedNextFiveYears
175000000 USD
CY2020Q4 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
39000000 USD
CY2020Q4 crm Lessee Operating Lease Lease Not Yet Commenced Amount
LesseeOperatingLeaseLeaseNotYetCommencedAmount
1900000000 USD
CY2020Q4 crm Lessee Operating Lease Commitmentincluding Lease Notyet Commenced Amount
LesseeOperatingLeaseCommitmentincludingLeaseNotyetCommencedAmount
5400000000 USD

Files In Submission

Name View Source Status
0001108524-20-000047-index-headers.html Edgar Link pending
0001108524-20-000047-index.html Edgar Link pending
0001108524-20-000047.txt Edgar Link pending
0001108524-20-000047-xbrl.zip Edgar Link pending
crm-20201031.htm Edgar Link pending
crm-20201031.xsd Edgar Link pending
crm-20201031_cal.xml Edgar Link unprocessable
crm-20201031_def.xml Edgar Link unprocessable
crm-20201031_g1.jpg Edgar Link pending
crm-20201031_g2.jpg Edgar Link pending
crm-20201031_g3.jpg Edgar Link pending
crm-20201031_g4.jpg Edgar Link pending
crm-20201031_htm.xml Edgar Link completed
crm-20201031_lab.xml Edgar Link unprocessable
crm-20201031_pre.xml Edgar Link unprocessable
ex311-ceocertq3fy21.htm Edgar Link pending
ex312-cfocertq3fy21.htm Edgar Link pending
ex321-soxcertsq3fy21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending